Atlas Trials

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Clinical trial NCT06927648 · RECRUITING

Trial details

NCT number
NCT06927648
Sponsor
AstraZeneca
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2025-10-15
Primary completion
2029-12-30
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.